Table 1.

Global monitoring indicators for pilot introduction of DMPA-SC.

Global monitoring indicator	Purpose
Number of providers trained, by type	•This process indicator documents the number and type(s) of family planning service providers trained in the provision of DMPA-SC; helps track whether training is progressing as expected.
Number of DMPA-SC doses administered to clients	•This outcome indicator documents the number of DMPA-SC doses administered to clients, independent from other injectable products. •Provides the denominator for indicators on new users, switching from DMPA-IM, and switching from other modern methods.
Number and percent of DMPA-SC doses administered to first-time users of modern contraception (“new users”)a	•This outcome indicator documents the total number of new users of modern contraception reached with DMPA-SC, and the share of total DMPA-SC doses administered to first-time users, by health system level where relevant. •Helps determine the extent to which the product is reaching new users, as opposed to users who had previously used another modern method. •The denominator for the percent indicator is the number of DMPA-SC doses administered to clients.
Number and percent of DMPA-SC doses administered to clients under age 20, ages 20 to 24, ages 25 and older (Niger, Senegal, and Uganda only)	•This outcome indicator documents the extent to which providers administer DMPA-SC doses to adolescent girls and young women. •May indicate whether DMPA-SC is an attractive method choice for adolescent girls and young women. •May highlight areas where additional training on provision of family planning methods (and/or injectables) to adolescents could be needed. •The denominator for the percent indicator is the sum of doses administered to clients in each age category.
Number and percent of DMPA-SC doses administered to clients who switched from DMPA-IM (Burkina Faso, Senegal, and Uganda only)	•This outcome indicator documents the number and proportion of DMPA-SC doses administered to clients switching from DMPA-IM, in order to track an early concern of stakeholders that DMPA-SC—a more expensive product at the time—would potentially replace DMPA-IM. •May indicate whether women and/or providers prefer DMPA-SC to DMPA-IM. •May indicate need to follow up with providers during supervision to ensure DMPA-SC is not promoted as a replacement for DMPA-IM. •The denominator for the percent indicator is the number of DMPA-SC doses administered to clients.
Number and percent of DMPA-SC doses administered to clients who switched from modern methods other than DMPA-IM (Burkina Faso and Senegal only)	•This outcome indicator documents the number of DMPA-SC doses administered to clients switching from modern methods other than DMPA-IM. •The denominator for the percent indicator is the number of DMPA-SC doses administered to clients.
Number of DMPA-IM doses administered to clients	•This outcome indicator documents the volume of DMPA-IM doses administered to clients, independent from other injectable products. •Provides input for the numerator and denominator for the indicator on relative proportions of DMPA-SC and DMPA-IM administered, by level.
Relative proportions of DMPA-SC and DMPA-IM administered, by level (where both methods are available)	•This outcome indicator documents the relative share of the market comprised of DMPA-SC and of DMPA-IM, by level, where providers offer both methods. •May indicate the preference of women and/or providers for each method, though factors such as provider skill level and potential bias should also be considered. •Numerators include the number of doses of DMPA-SC and DMPA-IM administered to clients. The denominator is the sum of the number of doses of DMPA-SC and DMPA-IM administered to clients.
Number of DMPA-SC doses distributed to health facilities	•This process indicator monitors functioning of the commodities distribution system. Documents the extent to which DMPA-SC is delivered and available for clients.
Number and percent of facilities with a stockout of DMPA-SC	•This outcome indicator documents the extent of DMPA-SC stockouts and contextualizes trends in DMPA-SC consumption and in the overall method mix. •Helps identify locations where the distribution system and/or facility stock management practices may require reinforcement. •The denominator for the percent indicator is the number of facilities active in the provision of DMPA-SC that reported during the same period.
Number of facilities active in the provision of DMPA-SC that reported this period	•This process indicator documents the number of facilities that reported on DMPA-SC in a given period. •Provides input on data completeness. •Provides the denominator for the percent of facilities with a stockout of DMPA-SC.

^aA first-time user of modern contraception—also referred to as “new user”—is defined as a client who has elected to use modern contraception for the first time in her life.